Track topics on Twitter Track topics that are important to you
Chugai Pharmaceutical Co., Ltd. announced that Chugai Pharma Taiwan Ltd., a wholly owned subsidiary of Chugai, obtained approval from the Taiwan Food and Drug Administration (TFDA), for "Alecensa,"
Japanese drug major Chugai Pharmaceutical says it has obtained approval from the Ministry of Health,…
Chugai Pharmaceutical, which is majority-owned by Swiss pharma giant Roche, has filed an application…
Chugai Pharmaceutical Co., Ltd. (TOKYO:4519) today announced that full results from HAVEN 3 study (NCT02847637) and HAVEN 4 study (NCT03020160) evaluating Chugai's hemophilia A treatment HEMLIBRA ...
Shares in Japanese drugmaker Chugai Pharmaceutical are up almost 5% on news that the China Food and Drug…
Chugai Pharmaceutical's Tecentriq, or atezolizumab, intravenous infusion 1,200 mg was launched in Japan as treatment for pati -More-
Chugai Pharmaceutical] announced today that it has decided to waive its claim in a patent infringement…
Japan’s Chugai Pharmaceutical has launched Tecentriq (atezolizumab, an intravenous Infusion) recombinant…
Cetirizine Hydrochloride Syrup
The properties of many drugs which have been available on the pharmaceutical market for a long time still need to be improved. Cocrystals are the solid state drug modification which can improve such p...
This study aimed to examine a detailed breakdown of costs (absenteeism, presenteeism, and medical/pharmaceutical expenses), of the employees in four pharmaceutical companies in Japan.
Cocrystals can be used as an alternative approach based on crystal engineering to enhance specific physicochemical and biopharmaceutical properties of active pharmaceutical ingredients (APIs) when the...
Although excipients are pharmacologically inert substances, still they are integral and significant ingredients of a pharmaceutical formulation. Their amount and concentration level along with the act...
The non-medical use (NMU) of pharmaceutical drugs is an increasing public health concern. This systematic review consolidates current knowledge about how pharmaceutical drugs are obtained for NMU and ...
The objective of this study is to evaluate the therapeutic effectiveness and cost-effectivity of pharmaceutical care for asthma patients.
The objective of this study is to evaluate the therapeutic effectiveness and cost-effectivity of pharmaceutical care for diabetes type 2 patients. Patients will be randomly allocated to th...
The aim of the project is to evaluate effectiveness of a multidimensional pharmaceutical care plan in improving compliance among elderly polypharmacy users at community pharmacy settings. ...
The primary objective of this study is to evaluate the impact of the implementation of collaborative pharmaceutical care on drug support at admission for patients 65 years of age and older...
The purpose of the study is to investigate the impact of pharmaceutical care on cancer pain treatment for opioid-tolerant outpatients
Chugai Pharmaceutical Co., Ltd is headquartered in Tokyo, Japan. In its home market, Chugai is a household name, with a broad-ranging product portfolio encompassing highly specialised therapeutic anti...
European headquarters of Chugai Pharmaceutical Co. Ltd. and Chugai Pharma UK Ltd.
Chugai Pharmaceutical Co., Ltd. places tremendous importance on the safekeeping of personal information obtained from customers using our website (information that is personally identifiable such as y...
We have published hundreds of Chugai Pharmaceutical Co., Ltd news stories on BioPortfolio along with dozens of Chugai Pharmaceutical Co., Ltd Clinical Trials and PubMed Articles about Chugai Pharmaceutical Co., Ltd for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Chugai Pharmaceutical Co., Ltd Companies in our database. You can also find out about relevant Chugai Pharmaceutical Co., Ltd Drugs and Medications on this site too.